- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Zydus secured Health Canada approval for Liothyronine tablets (5mcg & 25mcg) for hypothyroidism. This expansion targets a Canadian market with annual sales of 10.9 mn CAD, leveraging its Ahmedabad SEZ plant for manufacturing.